Extracellular proximal interaction profiling by cell surface–targeted TurboID reveals LDLR as a partner of liganded EGFR
A modified form of TurboID identifies extracellular interactions between transmembrane proteins.
A modified form of TurboID identifies extracellular interactions between transmembrane proteins.
The biomedical research agency’s 17th director is proud of her initiatives amid tough political landscape
The impacts of degradation and deforestation on tropical forests are poorly understood, particularly at landscape scales. We present an extensive ecosystem analysis of the impacts…
If we’ve learned anything from the Age of AI, it’s that the industry is grappling with significant power challenges. These challenges are both literal—as in…
Abu Mirza, GE HealthCare’s global SVP of digital products and engineering, joined MobiHealthNews during JPM to discuss the company’s efforts to leverage AI to improve…
A putative lipid binding site in the cytoplasmic domain of the human P2X4 receptor modulates the rate of desensitization.
This researcher shares four strategies she employed
The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology license.
Self-funded Pennsylvania-based health plan Imagine360 is buying Ardent Health’s third-party administrator (TPA) HealthFirst, the two companies revealed Jan. 15. | Alternative health plan Imagine360 is…
Made like miniature chainmail armor, these polymers have strange—and useful—properties
OpenAI is making a foray into scientific discovery with an AI built to help manufacture stem cells.